Challenges in antigenic characterization of circulating influenza a(H3N2) viruses during the 2011-2012 influenza season: An ongoing problem?

Journal of Clinical Microbiology

Volumn 53, Issue 5, 2015, Pages 1493-1499

  Kossyvakis, Athanasios ^a   Pogka, Vasiliki ^a   Melidou, Aggeliki ^b   Moutousi, Afroditi ^a   Gioula, Georgia ^b   Kalliaropoulos, Antonios ^a   Exindari, Maria ^b   Emmanouil, Mary ^a   Horefti, Elina ^a   Spala, Georgia ^c   Meijer, Adam ^d   Malisiovas, Nikolaos ^b   Mentis, Andreas F ^a  

^a HELLENIC PASTEUR INSTITUTE   (Greece)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^c Hellenic Centre for Disease Control and Prevention   (Greece)

^d NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HEMAGGLUTININ; OSELTAMIVIR; VIRUS ANTIGEN; INFLUENZA VIRUS HEMAGGLUTININ;

ARTICLE; CLADISTICS; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC VARIABILITY; GLYCOSYLATION; GREECE; HEMAGGLUTINATION INHIBITION TEST; HUMAN; INFLUENZA A (H3N2); INFLUENZA A VIRUS PERTH 16 2009; INFLUENZA A VIRUS VICTORIA 208; INFLUENZA VIRUS A H3N2; MAJOR CLINICAL STUDY; NONHUMAN; PHYLOGENY; PRIORITY JOURNAL; SEASONAL INFLUENZA; SEQUENCE ANALYSIS; STANDARDIZATION; VIRUS CHARACTERIZATION; VIRUS STRAIN; WINTER; ADOLESCENT; ADULT; AGED; ANIMAL; CHEMISTRY; CHILD; CLASSIFICATION; CLUSTER ANALYSIS; DNA SEQUENCE; FEMALE; GENETICS; GENOTYPE; IMMUNOLOGY; INFANT; INFLUENZA A VIRUS (H3N2); INFLUENZA, HUMAN; ISOLATION AND PURIFICATION; MALE; MIDDLE AGED; NEWBORN; PHENOTYPE; PRESCHOOL CHILD; VERY ELDERLY; VIROLOGY; YOUNG ADULT;

INFLUENZA A VIRUS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ANTIGENS, VIRAL; CHILD; CHILD, PRESCHOOL; CLUSTER ANALYSIS; FEMALE; GENOTYPE; GREECE; HEMAGGLUTINATION INHIBITION TESTS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFANT; INFANT, NEWBORN; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA, HUMAN; MALE; MIDDLE AGED; PHENOTYPE; PHYLOGENY; SEQUENCE ANALYSIS, DNA; YOUNG ADULT;

EID: 84928036876     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.03236-14     Document Type: Article

References (31)

1. Fiore AE, Uyeki TM, Broder K, Finelli L, Euler GL, Singleton JA, Iskander JK, Wortley PM, Shay DK, Bresee JS, Cox NJ. 2010. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep 59(RR-8):1-62. http://www.cdc.gov/mmwr/pdf/rr/rr5908.pdf.
2. Gamblin SJ, Skehel JJ. 2010. Influenza hemagglutinin and neuraminidase membrane glycoproteins. J Biol Chem 285:28403-28409. http://dx.doi .org/10.1074/jbc.R110.129809.
3. Medina RA, Garcia-Sastre A. 2011. Influenza A viruses: new research developments. Nat Rev Microbiol 9:590-603. http://dx.doi.org/10.1038/nrmicro2613.
4. World Health Organization. 2012. Vaccines against influenza. Wkly Epidemiol Rec 87:461-476. http://www.who.int/wer/2012/wer8747.pdf?ua-1.
5. Shih AC, Hsiao TC, Ho MS, Li WH. 2007. Simultaneous amino acid substitutions at antigenic sites drive influenza A hemagglutinin evolution. Proc Natl Acad Sci U S A 104:6283-6288. http://dx.doi.org/10.1073/pnas .0701396104.
6. Popova L, Smith K, West AH, Wilson PC, James JA, Thompson LF, Air GM. 2012. Immunodominance of antigenic site B over site A of hemagglutinin of recent H3N2 influenza viruses. PLoS One 7:e41895. http://dx .doi.org/10.1371/journal.pone.0041895.
7. Wiley DC, Wilson IA, Skehel JJ. 1981. Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature 289:373-378. http://dx.doi .org/10.1038/289373a0.
8. Bush RM, Bender CA, Subbarao K, Cox NJ, Fitch WM. 1999. Predicting the evolution of human influenza A. Science 286:1921-1925. http://dx.doi .org/10.1126/science.286.5446.1921.
9. Skehel JJ, Stevens DJ, Daniels RS, Douglas AR, Knossow M, Wilson IA, Wiley DC. 1984. A carbohydrate side chain on hemagglutinins of Hong Kong influenza viruses inhibits recognition by a monoclonal antibody. Proc Natl Acad Sci U S A 81:1779-1783. http://dx.doi.org/10.1073/pnas .81.6.1779.
10. Melidou A, Exindari M, Gioula G, Chatzidimitriou D, Pierroutsakos Y, Diza-Mataftsi E. 2009. Molecular and phylogenetic analysis and vaccine strain match of human influenza A(H3N2) viruses isolated in northern Greece between 2004 and 2008. Virus Res 145:220-226. http://dx.doi.org/10.1016/j.virusres.2009.07.006.
11. Kitler ME, Gavinio P, Lavanchy D. 2002. Influenza and the work of the World Health Organization. Vaccine 20(Suppl 2):S5-S14. http://dx.doi .org/10.1016/S0264-410X(02)00121-4.
12. World Health Organization. 2010. Selection of clinical specimens for virus isolation and of viruses for shipment from National Influenza Centres to WHO Collaborating Centres: 6 December 2010. World Health Organization, Geneva, Switzerland. http://www.who.int/influenza/gisrs-laboratory/national-influenza-centres/20101206-specimens-selected-for-virus-isolation-and-shipment.pdf?ua-1.
13. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S. 2011. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 28:2731-2739. http://dx.doi.org/10.1093/molbev/msr121.
14. Saitou N, Nei M. 1987. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 4:406-425.
15. Kimura M. 1980. A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J Mol Evol 16:111-120. http://dx.doi.org/10.1007/BF01731581.
16. Felsenstein J. 1985. Confidence limits on phylogenies: an approach using the bootstrap. Evolution 39:783-791. http://dx.doi.org/10.2307/2408678.
17. WHO Global Influenza Surveillance Network. 2011. Manual for the laboratory diagnosis and virological surveillance of influenza. World Health Organization, Geneva, Switzerland. http://whqlibdoc.who.int/publications/2011/9789241548090-eng.pdf.
18. WHO Collaborating Centre for Reference and Research on Influenza. 2013. Report prepared for the WHO annual consultation on the composition of influenza vaccine for the Southern Hemisphere 2013. National Institute for Medical Research, London, United Kingdom. http://www.ni mr.mrc.ac.uk/documents/about/Interim-Report-September-2012-2 .pdf.
19. Pariani E, Amendola A, Ebranati E, Ranghiero A, Lai A, Anselmi G, Zehender G, Zanetti A. 2013. Genetic drift influenza A(H3N2) virus hemagglutinin (HA) variants originated during the last pandemic turn out to be predominant in the 2011-2012 season in northern Italy. Infect Genet Evol 13:252-260. http://dx.doi.org/10.1016/j.meegid.2012.10.019.
20. European Centre for Disease Prevention and Control. 2012. Main surveillance developments in weeks 27-28, 2012 (2-15 July 2012). European Centre for Disease Prevention and Control, Stockholm, Sweden. http:// ecdc.europa.eu/en/publications/Publications/120720-SUR-WISO .pdf.
21. Koel BF, Burke DF, Bestebroer TM, van der Vliet S, Zondag GC, Vervaet G, Skepner E, Lewis NS, Spronken MI, Russell CA, Eropkin MY, Hurt AC, Barr IG, de Jong JC, Rimmelzwaan GF, Osterhaus AD, Fouchier RA, Smith DJ. 2013. Substitutions near the receptor binding site determine major antigenic change during influenza virus evolution. Science 342:976-979. http://dx.doi.org/10.1126/science.1244730.
22. Wilson IA, Cox NJ. 1990. Structural basis of immune recognition of influenza virus hemagglutinin. Annu Rev Immunol 8:737-771. http://dx .doi.org/10.1146/annurev.iy.08.040190.003513.
23. Tate MD, Job ER, Deng YM, Gunalan V, Maurer-Stroh S, Reading PC. 2014. Playing hide and seek: how glycosylation of the influenza virus hemagglutinin can modulate the immune response to infection. Viruses 6:1294-1316. http://dx.doi.org/10.3390/v6031294.
24. European Centre for Disease Prevention and Control. 2012. Main surveillance developments in week 8/2012 (20-26 Feb 2012). European Centre for Disease Prevention and Control, Stockholm, Sweden. http://e cdc.europa.eu/en/publications/Publications/120302-SUR-weekly-influenza-surveillance-overview.pdf.
25. WHO Collaborating Centre for Reference and Research on Influenza. 2012. Report prepared for the WHO annual consultation on the composition of influenza vaccine for the Southern Hemisphere 2013. National Institute for Medical Research, London, United Kingdom.
26. Lin YP, Gregory V, Collins P, Kloess J, Wharton S, Cattle N, Lackenby A, Daniels R, Hay A. 2010. Neuraminidase receptor binding variants of human influenza A(H3N2) viruses resulting from substitution of aspartic acid 151 in the catalytic site: a role in virus attachment? J Virol 84:6769-6781. http://dx.doi.org/10.1128/JVI.00458-10.
27. Ampofo WK, Al Busaidy S, Cox NJ, Giovanni M, Hay A, Huang S, Inglis S, Katz J, Mokhtari-Azad T, Peiris M, Savy V, Sawanpanyalert P, Venter M, Waddell AL, Wickramasinghe G, Zhang W, Ziegler T. 2013. Strengthening the influenza vaccine virus selection and development process: outcome of the 2nd WHO Informal Consultation for Improving Influenza Vaccine Virus Selection held at the Centre International de Conferences (CICG) Geneva, Switzerland, 7 to 9 December 2011. Vaccine 31:3209-3221. http://dx.doi.org/10.1016/j.vaccine.2013.05.049.
28. Schild GC, Oxford JS, de Jong JC, Webster RG. 1983. Evidence for host-cell selection of influenza virus antigenic variants. Nature 303:706-709. http://dx.doi.org/10.1038/303706a0.
29. WHO Collaborating Centre for Reference and Research on Influenza. 2013. Report prepared for the WHO annual consultation on the composition of influenza vaccine for the Northern Hemisphere 2013/14. National Institute for Medical Research, London, United Kingdom. http://www. nimr.mrc.ac.uk/documents/about/Interim-Report-February-2013.pdf.
30. WHO Collaborating Centre for Reference and Research on Influenza. 2014. Report prepared for the WHO annual consultation on the composition of influenza vaccine for the Northern Hemisphere 2014/15. National Institute for Medical Research, London, United Kingdom. http://www. nimr.mrc.ac.uk/documents/about/NIMR-report-Feb2014-web .pdf.
31. Sun H, Yang J, Zhang T, Long L, Jia K, Yang G, Webby R, Wan X. 2013. Using sequence data to infer the antigenicity of influenza virus. mBio 4(4):e00230-13. http://dx.doi.org/10.1128/mBio.00230-13.